CD44 and breast adenocarcinoma: Cortactin might increase the risk of breast adenocarcinoma metastasis to bone marrow mediated by hyaluronan/cluster of differentiation-44 (CD44) signaling in MCF-7 cell lines indicating that the expression level of CTTN can be positively regulated by CD44 [77].